Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- Check3 days agoChange DetectedThe page footer revision label was updated from v3.6.5 to v3.6.6. This signals a small update to the page template or content management system without changing the displayed study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a deployment of a newer site template used to render the study details.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new site software release. The change does not modify the study details or visible content on the page.SummaryDifference0.1%

- Check67 days agoChange DetectedThe revision tag on the page changed from v3.6.0 to v3.6.3. This reflects a minor update to the page's documentation/metadata rather than its content.SummaryDifference0.1%

- Check81 days agoChange DetectedNew help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision tag was updated to v3.6.0. The wording of the 'Intervention/Treatment' section was standardized from 'Intervention / Treatment', and older labels such as 'Verified' and 'Last known status was:' were removed.SummaryDifference2%

- Check88 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new build of the page. This reflects a minor update to the page's version.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.